| Literature DB >> 32952468 |
Philip K Louie1, Lauren A Barber1, Kyle W Morse1, Marie Syku1, Sheeraz A Qureshi1, Virginie Lafage1, Russel C Huang1, Alberto V Carli1.
Abstract
BACKGROUND: Healthcare resources have been greatly limited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic halting non-essential surgical cases without clear service expansion protocols. QUESTIONS/PURPOSES: We sought to compare the peri-operative outcomes of patients undergoing spine surgery during the SARS-CoV-2 pandemic to a matched cohort prior to the pandemic.Entities:
Keywords: COVID-19; SARS-CoV-2; coronavirus; elective surgery; orthopedics; spine surgery; telemedicine
Year: 2020 PMID: 32952468 PMCID: PMC7491022 DOI: 10.1007/s11420-020-09797-x
Source DB: PubMed Journal: HSS J ISSN: 1556-3316
Defining essential surgery at our institution
| All service lines | |
| Any infection, chronic or acute, requiring surgical intervention | |
| Any surgical wounds requiring surgical intervention | |
| Compartment syndrome | |
| Dislocation of native or prosthetic joint requiring reduction in the OR | |
| Malignant or benign tumors with impending fracture or neurovascular compromise | |
| Fractures (peri-prosthetic or native bone) | |
| Tendon injuries requiring surgical intervention | |
| Any loose body in the joint or displaced cartilage causing a locked joint | |
| Any injury to the lower extremity where the patient has an inability to bear weight or walk | |
| Any vascular or neurologic injuries | |
| Any injury where prompt intervention significantly improves outcomes | |
| Spine surgery | |
| Progressive weakness on physical exam or weakness with active denervation on EMG | |
| Myelopathy with cord at risk | |
| Fracture or trauma with spinal instability | |
| Cauda equina syndrome |
Fig. 1Heatmap representing primary residence of surgical patients. This heatmap depicts the location of the surgical patients’ primary residence. The numbers listed describe the number of patients who reside in that respective state. The greatest density of patients presented from downstate New York.
Patient demographics and surgical indications
| Operated during pandemic (mean ± standard deviation) | Historical cohort | ||
|---|---|---|---|
| 127 | 127 | - | |
| Age (years) | 59.8 ± 13.4 | 60.3 ± 12.3 | 0.917 |
| Gender (male:female) | 79:48 | 79:48 | 0.263 |
| BMI | 29.1 ± 5.2 | 29.1 ± 4.8 | 0.809 |
| ASA score | 2.1 ± 0.4 | 2.1 ± 0.4 | 0.764 |
| Charlson comorbidity score | 1.6 ± 1.6 | 1.5 ± 1.1 | 0.823 |
| Indication for surgery | 0.530 | ||
| Intractable pain | 116 | 116 | |
| Sensory deficit | 87 | 83 | |
| Motor weakness (radicular) | 64 | 63 | |
| Myelopathy | 19 | 15 |
Peri-operative outcomes
| Operated during pandemic (mean ± standard deviation) | Historical cohort | ||
|---|---|---|---|
| Type of surgery | < 0.01* | ||
| Ambulatory | 12 | 14 | |
| Inpatient | 115 | 113 | |
| Location of surgery | 0.935 | ||
| Cervical | 43 | 42 | |
| Thoracic | 2 | 4 | |
| Thoracolumbar | 82 | 81 | |
| Surgical procedures | 0.645 | ||
| Lumbar decompression/discectomy | 41 | 44 | |
| ACDF/CDR | 36 | 38 | |
| Lumbar fusion | 32 | 41 | |
| Posterior cervical surgery | 7 | 7 | |
| Other | 11 | 7 | |
| Surgical duration (h:min) | 2:42 ± 1:29 | 2:38 ± 1:46 | 0.273 |
| Intra-operative complications (total) | 5 | 8 | 0.419 |
| Post-operative complications | 16 | 0.464 | |
| Dysphagia | 7 | 3 | |
| New-onset motor weakness | 4 | 4 | |
| Wound drainage | 3 | 0 | |
| New-onset atrial fibrillation | 2 | 1 | |
| Urinary tract infection | 2 | 4 | |
| Pulmonary embolism | 1 | 0 | |
| Pneumonia | 1 | 2 | |
| Hematoma | 0 | 1 | |
| Ileus | 0 | 1 | |
| Death | 1 | 0 |
Post-operative outcomes
| Operated during pandemic (mean ± standard deviation) | Historical cohort | ||
|---|---|---|---|
| Length of stay (days) | 3.1 ± 4.2 | 2.6 ± 3.0 | 0.540 |
| Follow-up post-discharge | |||
| Formal telemedicine visit | 80 | 0 | 1.0 |
| Telephone call | 127 | 127 | |
| In-person visit | 3 | 121 | |
| Tested for COVID: COVID +ve | 1.0 | ||
| In-hospital: positive | 8:0 | 0:0 | |
| Following discharge: positive | 3:0 | 0:0 | |
| Fever | 0.680 | ||
| In-hospital: COVID +ve | 9:0 | 5:0 | |
| Post-discharge: COVID +ve | 8:0 | 2:0 | |
| Respiratory symptoms | 0.111 | ||
| In-hospital: COVID +ve | 2:0 | 1:0 | |
| Post-discharge: COVID +ve | 3:0 | 0:0 | |
| Required blood transfusion post-operatively | 4 | 10 | |
| Re-admission within 30 days | 3 | 7 | 0.057 |
| Re-operation within 30 days | 3 | 5 | 0.327 |
| Mortality within 30 days | 1 | 0 | - |
Fig. 2Surgical volume and pertinent milestones during the pandemic. The graph represents cumulative surgical volume over the study period. Specific milestones are described and marked by a vertical line. On March 16, 2020, PPE became widely available for all hospital staff. The next day on March 17, the hospital suspended all elective surgeries. On March 23, COVID-19 testing became available for all inpatients and operative patients. Lastly on March 29, our hospital began accepting COVID-19-positive patients from a nearby hospital.